Eurand Announces NDA Filing by GSK

Eurand, a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies, announced that GlaxoSmithKline has filed a new drug application (NDA) with the Food and Drug Administration (FDA) for an orally disintegrating tablet formulation of a product codeveloped with Eurand using the company's Microcaps taste-masking and AdvaTab technologies.
CNN Money